ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million
Go back to ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 76.14 +0.75 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $75.39 | 52 Week High | $70.92 | |||
| Open | $75.88 | 52 Week Low | $26.80 | |||
| Day High | $77.41 | P/E | N/A | |||
| Day Low | $74.21 | EPS | $-0.96 | |||
| Volume | 1,160,356 | |||||
